Table 7 Log-rank test results for dogs with idiopathic and structural epilepsy
Variables | All epilepsy cases (years) | IdE (years) | StE (years) | ||||||
|---|---|---|---|---|---|---|---|---|---|
n (dead) | median (95 % CI) | P value | n (dead) | median (95 % CI) | P value | n (dead) | median (95 % CI) | P value | |
Gender | |||||||||
Male | 52 (30) | 8.9 (5.6–11.8) | 0.26 | 37 (18) | 11.3 (7.3–12.6) | 0.45 | 15 (12) | 4.5 (0.4–10.4) | 0.20 |
Female | 42 (13) | 10.1 (9.2–∞) | 27 (7) | 10.1 (9.2–∞) | 15 (6) | NA (1.9–∞) | |||
Status of neuter | |||||||||
Intact | 53 (26) | 10.2 (8.1–11.8) | 0.31 | 35 (15) | 10.4 (8.9–14.5) | 0.31 | 18 (11) | 10.2 (1.3–∞) | 0.46 |
Neuter | 41 (17) | 9.3 (6.3–∞) | 29 (10) | 9.3 (6.3–∞) | 12 (7) | 6.7 (0.4–∞) | |||
Body weight | |||||||||
< 6.6 kg | 47 (20) | 10.2 (6.7–14.5) | 0.26 | 31 (11) | 11.9 (7.5–∞) | 0.28 | 16 (9) | 6.7 (3.3–∞) | 0.27 |
≥ 6.6 kg | 47 (23) | 9.3 (7.1–10.4) | 33 (14) | 10.1 (7.3–∞) | 14 (9) | 4.0 (0.4–∞) | |||
Seizure frequency at last follow-up | |||||||||
< 0.3 sz/month | 48 (16) | 11.8 (10.4–14.5) | <0.01 | 37 (11) | 11.9 (11.3–14.5) | <0.01 | 11 (5) | 10.4 (0.58–∞) | 0.06 |
≥ 0.3 sz/month | 46 (27) | 7.3 (4.5–9.2) | 27 (14) | 8.9 (5.3–10.1) | 19 (13) | 4.5 (1.2–∞) | |||
Epileptic seizure type | |||||||||
FES | 20 (6) | 8.9 (3.3–∞) | 0.77 | 15 (4) | 8.9 (2.9–∞) | 0.20 | 5 (2) | NA (0.2–∞) | 0.89 |
GES | 51 (26) | 10.4 (7.3–11.9) | 30 (12) | 11.3 (10.1–14.5) | 21 (14) | 5.6 (1.2–10.4) | |||
FEvG | 23 (11) | 8.1 (6.3–∞) | 19 (9) | 9.2 (5.3–∞) | 4 (2) | 6.7 (6.7–∞) | |||
Development of CS | |||||||||
Yes | 43 (22) | 9.2 (4.1–11.3) | 0.06 | 26 (11) | 10.4 (4.1–∞) | 0.21 | 17 (11) | 4.5 (1.1–∞) | 0.18 |
No | 51 (21) | 10.1 (8.1–11.9) | 38 (14) | 10.1 (8.1–14.5) | 13 (7) | 6.7 (3.3–∞) | |||
Development of SE | |||||||||
Yes | 16 (9) | 10.1 (4.1–11.9) | 0.93 | 13 (7) | 10.1 (4.1–∞) | 0.42 | 3 (2) | 10.4 (3.3–∞) | 0.54 |
No | 78 (34) | 10.2 (7.5–11.8) | 51 (18) | 10.4 (8.9–∞) | 27 (16) | 6.7 (1.3–∞) | |||
Using AEDs at last follow-up | |||||||||
None or monotherapy | 58 (26) | 10.4 (7.1–12.6) | 0.48 | 37 (14) | 11.9 (7.5–14.5) | 0.29 | 22 (12) | 5.6 (1.3–∞) | 0.50 |
Polytherapy | 36 (17) | 9.3 (6.7–10.4) | 27 (11) | 9.3 (7.3–11.3) | 8 (6) | 6.7 (1.1–∞) | |||